Details for New Drug Application (NDA): 217151
✉ Email this page to a colleague
NDA 217151 describes VARENICLINE TARTRATE, which is a drug marketed by Ajanta Pharma Ltd, Alkem Labs Ltd, Apotex, Bionpharma, Dr Reddys, Endo Operations, Hetero Labs Ltd Iii, Indoco, Leading Pharma, Lupin Ltd, Mankind Pharma, Mylan, Piramal, and Zydus, and is included in fourteen NDAs. It is available from twenty-three suppliers. Additional details are available on the VARENICLINE TARTRATE profile page.
The generic ingredient in VARENICLINE TARTRATE is varenicline tartrate. There are twelve drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the varenicline tartrate profile page.
The generic ingredient in VARENICLINE TARTRATE is varenicline tartrate. There are twelve drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the varenicline tartrate profile page.
Summary for 217151
| Tradename: | VARENICLINE TARTRATE |
| Applicant: | Leading Pharma |
| Ingredient: | varenicline tartrate |
| Patents: | 0 |
Pharmacology for NDA: 217151
| Mechanism of Action | Cholinergic Agonists Partial Cholinergic Nicotinic Agonists |
Medical Subject Heading (MeSH) Categories for 217151
Suppliers and Packaging for NDA: 217151
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| VARENICLINE TARTRATE | varenicline tartrate | TABLET;ORAL | 217151 | ANDA | Leading Pharma, LLC | 69315-402 | 69315-402-56 | 56 TABLET, FILM COATED in 1 BOTTLE (69315-402-56) |
| VARENICLINE TARTRATE | varenicline tartrate | TABLET;ORAL | 217151 | ANDA | Leading Pharma, LLC | 69315-403 | 69315-403-56 | 56 TABLET, FILM COATED in 1 BOTTLE (69315-403-56) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 0.5MG BASE | ||||
| Approval Date: | Jul 25, 2023 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 1MG BASE | ||||
| Approval Date: | Jul 25, 2023 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
